Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-043897

CEO and President bought 1,000 shares at $9.87 ($9,870)

From the SEC's structured data for this filing

Trades in this filing

Kendall Keith J · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-27 Purchase : show line 1 in the form +1,000 $9.87 $9,870 621,139 D
Open-market purchases · 1,000 sh · avg $9.87 · $9,870
Loading xslF345X03/form4.xml…